Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)
Clinical trial NCT03428646 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03428646
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2018-04-06
- Primary completion
- 2027-03-30
- Enrollment
- 858
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.